Genky DrugStores’ FY2026 first-half financial supplement shows achieved sales of approximately 244 billion yen (YoY +10.6%), with store count also expanding. The company continues to pursue aggressive store expansion and revenue growth.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"9267","jir_company_name":"Genky DrugStores","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-07-28","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/9267-20260728-04.pdf","jir_short_summary":"Genky DrugStores' FY2026 first-half financial supplement shows achieved sales of approximately 244 billion yen (YoY +10.6%), with store count also expanding. The company continues to pursue aggressive store expansion and revenue growth.","jir_summary":"### Performance Overview\nIn the first half of FY2026, Genky DrugStores achieved sales of approximately 244 billion yen (YoY +10.6%), expanding its store count to 604 locations. The increase in sales from new openings and existing stores has improved profitability. Net income remained steady at approximately 220 million yen, indicating a solid performance, and the company maintains its goal of active store expansion and revenue growth.\n\n### Future Outlook and Impact on Shareholders\nThe company will continue its active store expansion strategy, aiming to maintain sales of approximately 244 billion yen and over 600 stores in FY2027. Net income is expected to remain steady, and shareholder return measures such as maintaining dividends and treasury stock acquisitions are also suggested. Investors can expect stable growth and improved earnings performance.","jir_financial_highlights":"Sales: approximately 244 billion yen (YoY +10.6%)\nNumber of Stores: 604 stores (increasing)\nNet Income: approximately 220 million yen (YoY +12.4%)","jir_category":"","jir_hashtags":"#GenkyDrugStores, #IR, #JapaneseStocks","jir_key_figures":"Sales: approximately 244 billion yen (YoY +10.6%)\nNumber of Stores: 604 stores\nNet Income: approximately 220 million yen (YoY +12.4%)","jir_meta_title":"\u3010Genky DrugStores\u3011FY2026 First Half Financial Results | Sales of approximately 244 billion yen increase","jir_meta_description":"Genky DrugStores' FY2026 first-half financial supplement shows achieved sales of approximately 244 billion yen (YoY +10.6%), with store expansion and revenue improvement.","jir_og_title":"\u3010Genky DrugStores\u3011FY2026 First Half Financial Results | Sales of approximately 244 billion yen increase","jir_og_description":"Overview of Genky DrugStores' FY2026 first-half financial results and future outlook. Sales of approximately 244 billion yen, with 604 stores expanded.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":9174,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-88914","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n